Table 1 Summarized characteristics of DAVFs among patients with CVST* (n = 15)
Parameter | Value |
|---|---|
Sex | |
male | 9(60.00) |
female | 6(40.00) |
Age, years (IQR) | 33 (28–48) |
Clinical Symptom at diagnosis of DAVFs | |
Headache | 7(46.67) |
Visual disturbance | 7(46.67) |
Pulsatile tinitus | 5(33.33) |
Nausea/vomiting | 2 (13.33) |
Ophthalmodynia | 1 (6.67) |
Dysarthria | 1 (6.67) |
Sensory disturbance | 1 (6.67) |
Unsteady gait | 1 (6.67) |
Exophthalmoses | 1 (6.67) |
Varicose veins in the scalp | 1 (6.67) |
Papilledema | 9 (60.00) |
Intracranial hypertension, n (%) | 10 (66.67) |
Location of CVST, n (%) | |
Superior sagittal sinus | 10 (66.67) |
Transverse sinus | 10 (66.67) |
Sigmoid sinus | 5(33.33) |
Confluence sinus | 5(33.33) |
Straight sinus | 2 (13.33) |
Jugular vein | 2 (13.33) |
cortical venous thrombosis | 1 (6.67) |
Location of DAVFs, n (%) | |
Transverse/ Sigmoid sinus | 7% (46.67) |
Superior sagittal sinus | 6% (40.00) |
Confluence of sinuses | 6% (40.00) |
Occipital sinus | 1 (6.7) |
Jugular foramen | 1 (6.7) |
Cognard’s classification of dAVFs, n (%) | |
Cognard 1 | 7 (46.67) |
Cognard IIa | 3 (20.00) |
Cognard II b | 1 (6.67) |
Cognard III | 1 (6.67) |
Cognard IV | 3 20.00) |
Borden classification | |
Borden 1 | 7 (46.67) |
Borden 1I | 4 (26. 67) |
Borden 1II | 4 (26. 67) |
Outcome at last follow-up | |
Median follow-up duration | 17(8–36) |
Good outcome (last mRS 0–2) | 15(100) |